CY1121053T1 - Ενα γονιδιο που κωδικοποιει ενα ομολογο ανθρωπινης ρ-γλυκοπρωτεϊνης με ανθεκτικοτητα απεναντι σε πολλαπλα φαρμακα πανω στο χρωμοσωμα 7p15-21 και χρησεις αυτου - Google Patents
Ενα γονιδιο που κωδικοποιει ενα ομολογο ανθρωπινης ρ-γλυκοπρωτεϊνης με ανθεκτικοτητα απεναντι σε πολλαπλα φαρμακα πανω στο χρωμοσωμα 7p15-21 και χρησεις αυτουInfo
- Publication number
- CY1121053T1 CY1121053T1 CY181100185T CY181100185T CY1121053T1 CY 1121053 T1 CY1121053 T1 CY 1121053T1 CY 181100185 T CY181100185 T CY 181100185T CY 181100185 T CY181100185 T CY 181100185T CY 1121053 T1 CY1121053 T1 CY 1121053T1
- Authority
- CY
- Cyprus
- Prior art keywords
- glycoprotein
- gene
- multiple drugs
- human
- codes
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 102100033350 ATP-dependent translocase ABCB1 Human genes 0.000 abstract 2
- 108010047230 Member 1 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 2
- 206010048723 Multiple-drug resistance Diseases 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 210000003917 human chromosome Anatomy 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Η εφεύρεση σχετίζεται με μία Ρ-γλυκοπρωτεΐνη της οικογένειας MDR που βρίσκεται πάνω στο ανθρώπινο χρωμόσωμα, με αλληλουχίες πολυνουκλεοτιδίου, που κωδικοποιούν αυτήν την Ρ-γλυκοπρωτεΐνη και θραύσματα αυτής. Αυτό το γονίδιο χρησιμοποιείται σε μεθόδους για τον προσδιορισμό της ευαισθησίας των καρκινικών κυττάρων σε θεραπείες που κατευθύνονται έναντι της ανθεκτικότητας σε πολλαπλά φάρμακα, και στον σχεδιασμό διαγνωστικών και θεραπευτικών μεθόδων, που σχετίζονται με την ανθεκτικότητα απέναντι σε πολλαπλά φάρμακα για τον καρκίνο. Αυτή η εφεύρεση σχετίζεται επίσης με μεθόδους για τον προσδιορισμό του κατά πόσον μία δοκιμαστική ένωση μπορεί να αναστείλει την ανθεκτικότητα σε πολλαπλά φάρμακα.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20891300P | 2000-06-05 | 2000-06-05 | |
EP09180026.8A EP2182005B1 (en) | 2000-06-05 | 2001-06-05 | A gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7p15-21 and uses thereof |
EP01941884A EP1290028B1 (en) | 2000-06-05 | 2001-06-05 | A GENE ENCODING A MULTIDRUG RESISTANCE HUMAN P-GLYCOPROTEIN HOMOLOGUE ON CHROMOSOME 7p15-21 AND USES THEREOF |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1121053T1 true CY1121053T1 (el) | 2019-12-11 |
Family
ID=22776565
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20101100281T CY1109941T1 (el) | 2000-06-05 | 2010-03-23 | ΕΝΑ ΓΟΝΙΔΙΟ ΠΟΥ ΚΩΔΙΚΟΠΟΙΕΙ ΕΝΑ ΟΜΟΛΟΓΟ ΑΝΘΡΩΠΙΝΗΣ Ρ-ΓΛΥΚΟΠΡΩΤΕΙΝΗΣ ΜΕ ΑΝΘΕΚΤΙΚΟΤΗΤΑ ΑΠΕΝΑΝΤΙ ΣΕ ΠΟΛΛΑ ΦΑΡΜΑΚΑ ΠΑΝΩ ΣΤΟ ΧΡΩΜΟΣΩΜΑ 7p15-21 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΟΥ |
CY181100185T CY1121053T1 (el) | 2000-06-05 | 2018-02-14 | Ενα γονιδιο που κωδικοποιει ενα ομολογο ανθρωπινης ρ-γλυκοπρωτεϊνης με ανθεκτικοτητα απεναντι σε πολλαπλα φαρμακα πανω στο χρωμοσωμα 7p15-21 και χρησεις αυτου |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20101100281T CY1109941T1 (el) | 2000-06-05 | 2010-03-23 | ΕΝΑ ΓΟΝΙΔΙΟ ΠΟΥ ΚΩΔΙΚΟΠΟΙΕΙ ΕΝΑ ΟΜΟΛΟΓΟ ΑΝΘΡΩΠΙΝΗΣ Ρ-ΓΛΥΚΟΠΡΩΤΕΙΝΗΣ ΜΕ ΑΝΘΕΚΤΙΚΟΤΗΤΑ ΑΠΕΝΑΝΤΙ ΣΕ ΠΟΛΛΑ ΦΑΡΜΑΚΑ ΠΑΝΩ ΣΤΟ ΧΡΩΜΟΣΩΜΑ 7p15-21 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΟΥ |
Country Status (11)
Country | Link |
---|---|
US (6) | US6846883B2 (el) |
EP (5) | EP2298799B1 (el) |
AT (1) | ATE452909T1 (el) |
CA (1) | CA2411101C (el) |
CY (2) | CY1109941T1 (el) |
DE (1) | DE60140868D1 (el) |
DK (4) | DK2298799T3 (el) |
ES (4) | ES2338756T3 (el) |
HK (2) | HK1143823A1 (el) |
PT (4) | PT1290028E (el) |
WO (1) | WO2001094400A2 (el) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2298799B1 (en) | 2000-06-05 | 2017-11-15 | The Brigham and Women's Hospital, Inc. | A gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof |
WO2003025174A2 (en) * | 2001-09-06 | 2003-03-27 | Bayer Healthcare Ag | Regulation of human mrp1-like protein |
EP2772535B1 (en) * | 2006-05-31 | 2022-04-06 | Children's Medical Center Corporation | ABC5 positive mesenchymal stem cells as immunomodulators |
HUE027593T2 (en) | 2007-04-12 | 2016-11-28 | Brigham & Womens Hospital Inc | ABCB5 targeting cancer therapy |
US11542328B2 (en) | 2008-11-14 | 2023-01-03 | The Brigham And Women's Hospital, Inc. | Therapeutic and diagnostic methods relating to cancer stem cells |
US20110287034A1 (en) | 2008-11-14 | 2011-11-24 | The Brigham And Womens Hospital, Inc. | Therapeutic and diagnostic methods relating to cancer stem cells |
CA2901931C (en) | 2013-02-19 | 2023-03-07 | Children's Medical Center Corporation | Abcb5(+) stem cells for treating ocular disease |
AU2014262590B2 (en) | 2013-05-10 | 2018-05-10 | Children's Medical Center Corporation | Wound healing and tissue engineering |
CA3030603A1 (en) * | 2016-07-14 | 2018-01-18 | University Of Southern California | Methods and composition for producing and using immune cells and stem cells for cell-based therapies |
CN116096753A (zh) * | 2020-04-30 | 2023-05-09 | 儿童医学中心公司 | 对abcb5具有特异性的抗体及其用途 |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0174810B1 (en) * | 1984-09-10 | 1993-07-21 | HSC Research Development Corporation | Multidrug resistance in mammalian cell lines and isolation of determinant glycoprotein dna |
US4837306A (en) | 1985-02-25 | 1989-06-06 | The Ontario Cancer Institute | Method for selecting hybridomas producing antibodies specific to the P-glycoprotein cell suface antigen and a cDNA clone encoding the C-terminal portion of the antigen |
US5693622A (en) | 1989-03-21 | 1997-12-02 | Vical Incorporated | Expression of exogenous polynucleotide sequences cardiac muscle of a mammal |
US5399483A (en) | 1989-03-30 | 1995-03-21 | Suntory Limited | Expression of MDR-related gene in yeast cell |
US5264618A (en) | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
US5434075A (en) * | 1992-03-20 | 1995-07-18 | Board Of Trustees Of The University Of Illinois | Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses |
IT1257893B (it) * | 1992-06-17 | 1996-02-16 | Ist Superiore Sanita | Anticorpi monoclonali che riconoscono un epitopo della p-glicoproteina umana. |
WO1994009363A1 (en) * | 1992-10-14 | 1994-04-28 | Board Of Regents, The University Of Texas System | Cancer diagnosis and therapy |
ATE480521T1 (de) | 1996-10-01 | 2010-09-15 | Kyowa Hakko Kirin Co Ltd | Stickstoff enthaltende heterocyclische verbindungen |
US6020191A (en) | 1997-04-14 | 2000-02-01 | Genzyme Corporation | Adenoviral vectors capable of facilitating increased persistence of transgene expression |
US6008002A (en) * | 1997-09-29 | 1999-12-28 | Bodey; Bela | Immunomagnetic detection and isolation of cancer cells |
CZ298347B6 (cs) * | 1998-02-05 | 2007-09-05 | Glaxosmithkline Biologicals S.A. | Fúzní protein z rodiny MAGE, kódová sekvence nukleové kyseliny, vektor, hostitelská bunka, vakcina a použití fúzního proteinu pro výrobu vakciny |
EP1062321B1 (en) | 1998-03-13 | 2004-12-29 | Osiris Therapeutics, Inc. | Uses for humane non-autologous mesenchymal stem cells |
AU785363B2 (en) * | 1999-09-28 | 2007-02-01 | Gentest Corporation | P-glycoproteins and uses thereof |
AU2001233114A1 (en) * | 2000-02-04 | 2001-08-14 | Aeomica, Inc. | Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence |
EP2298799B1 (en) | 2000-06-05 | 2017-11-15 | The Brigham and Women's Hospital, Inc. | A gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof |
DK1292680T3 (da) | 2000-06-22 | 2010-03-08 | Genentech Inc | Agonist-anti-TrkC monoklonale antistoffer |
WO2002040541A2 (en) * | 2000-10-27 | 2002-05-23 | Incyte Genomics, Inc. | Transporters and ion channels |
JP2007512017A (ja) * | 2003-11-24 | 2007-05-17 | ザ ロックフェラー ユニバーシティー | 自己複製多能性遅延周期細胞を単離する方法 |
US20050186672A1 (en) | 2004-01-27 | 2005-08-25 | Reliance Life Sciences Pvt. Ltd. | Tissue system with undifferentiated stem cells derived from corneal limbus |
US10538742B2 (en) | 2004-11-12 | 2020-01-21 | Cambridge Enterprise Limited | Methods and means related to cancer stem cells |
WO2006103685A2 (en) | 2005-03-28 | 2006-10-05 | Vision Research Foundation | A method for cultivating cells derived from corneal limbal tissue and cells deived from corneal limbal tissue |
EP1907858A4 (en) | 2005-06-13 | 2009-04-08 | Univ Michigan | COMPOSITIONS AND METHODS OF TREATMENT AND DIAGNOSIS OF CANCER |
EP2772535B1 (en) | 2006-05-31 | 2022-04-06 | Children's Medical Center Corporation | ABC5 positive mesenchymal stem cells as immunomodulators |
CA2698597A1 (en) * | 2006-09-07 | 2008-03-13 | Stemline Therapeutics, Inc. | Monitoring cancer stem cells |
HUE027593T2 (en) | 2007-04-12 | 2016-11-28 | Brigham & Womens Hospital Inc | ABCB5 targeting cancer therapy |
US20110287034A1 (en) | 2008-11-14 | 2011-11-24 | The Brigham And Womens Hospital, Inc. | Therapeutic and diagnostic methods relating to cancer stem cells |
CA2901931C (en) | 2013-02-19 | 2023-03-07 | Children's Medical Center Corporation | Abcb5(+) stem cells for treating ocular disease |
AU2014262590B2 (en) | 2013-05-10 | 2018-05-10 | Children's Medical Center Corporation | Wound healing and tissue engineering |
-
2001
- 2001-06-05 EP EP10185365.3A patent/EP2298799B1/en not_active Expired - Lifetime
- 2001-06-05 ES ES01941884T patent/ES2338756T3/es not_active Expired - Lifetime
- 2001-06-05 EP EP17201739.4A patent/EP3333182A1/en not_active Withdrawn
- 2001-06-05 ES ES10185365.3T patent/ES2659877T3/es not_active Expired - Lifetime
- 2001-06-05 ES ES09180026.8T patent/ES2540102T3/es not_active Expired - Lifetime
- 2001-06-05 PT PT01941884T patent/PT1290028E/pt unknown
- 2001-06-05 DE DE60140868T patent/DE60140868D1/de not_active Expired - Lifetime
- 2001-06-05 US US09/873,409 patent/US6846883B2/en not_active Expired - Lifetime
- 2001-06-05 DK DK10185365.3T patent/DK2298799T3/en active
- 2001-06-05 EP EP10151972.6A patent/EP2230253B1/en not_active Expired - Lifetime
- 2001-06-05 EP EP01941884A patent/EP1290028B1/en not_active Expired - Lifetime
- 2001-06-05 DK DK10151972.6T patent/DK2230253T3/da active
- 2001-06-05 PT PT101853653T patent/PT2298799T/pt unknown
- 2001-06-05 WO PCT/US2001/018032 patent/WO2001094400A2/en active Application Filing
- 2001-06-05 DK DK09180026.8T patent/DK2182005T3/en active
- 2001-06-05 PT PT91800268T patent/PT2182005E/pt unknown
- 2001-06-05 CA CA2411101A patent/CA2411101C/en not_active Expired - Lifetime
- 2001-06-05 ES ES10151972T patent/ES2434721T3/es not_active Expired - Lifetime
- 2001-06-05 AT AT01941884T patent/ATE452909T1/de active
- 2001-06-05 EP EP09180026.8A patent/EP2182005B1/en not_active Expired - Lifetime
- 2001-06-05 DK DK01941884.7T patent/DK1290028T3/da active
- 2001-06-05 PT PT101519726T patent/PT2230253E/pt unknown
-
2004
- 2004-09-29 US US10/952,328 patent/US7465554B2/en not_active Expired - Lifetime
-
2008
- 2008-11-19 US US12/273,849 patent/US8076091B2/en not_active Expired - Fee Related
-
2010
- 2010-02-09 US US12/702,570 patent/US8425876B2/en not_active Expired - Lifetime
- 2010-03-23 CY CY20101100281T patent/CY1109941T1/el unknown
- 2010-11-05 HK HK10110380.5A patent/HK1143823A1/xx not_active IP Right Cessation
-
2011
- 2011-10-24 US US13/279,549 patent/US8507273B2/en not_active Expired - Lifetime
-
2013
- 2013-07-10 US US13/938,938 patent/US9561264B2/en not_active Expired - Lifetime
-
2018
- 2018-02-14 CY CY181100185T patent/CY1121053T1/el unknown
- 2018-12-13 HK HK18116046.0A patent/HK1257165A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1121053T1 (el) | Ενα γονιδιο που κωδικοποιει ενα ομολογο ανθρωπινης ρ-γλυκοπρωτεϊνης με ανθεκτικοτητα απεναντι σε πολλαπλα φαρμακα πανω στο χρωμοσωμα 7p15-21 και χρησεις αυτου | |
Walker et al. | Emerging therapeutic targets for neurofibromatosis type 1 | |
CY1109557T1 (el) | ΠΡΟΣΔΙΟΡΙΣΜΟΣ ΑΝΙΧΝΕΥΣΗΣ ΓΟΝΙΔΙΟΥ ΓΙΑ ΒΕΛΤΙΩΣΗ ΤΗΣ ΠΙΘΑΝΟΤΗΤΑΣ ΑΠΟΤΕΛΕΣΜΑΤΙΚΗΣ ΑΠΟΚΡΙΣΗΣ ΣΕ ΚΑΡΚΙΝΙΚΗ ΘΕΡΑΠΕΙΑ ΑΝΤΑΓΩΝΙΣΤΗ ErbB | |
CY1110256T1 (el) | Διαμεμβρανικο αντιγονο λεκτινης τυπου c εκφραζομενο σε καρκινο στον προστατη ανθρωπου και χρησεις αυτου | |
Spenlé et al. | Tenascin-C: Exploitation and collateral damage in cancer management | |
Zhou et al. | Increased methylation of the MOR gene proximal promoter in primary sensory neurons plays a crucial role in the decreased analgesic effect of opioids in neuropathic pain | |
ATE353974T1 (de) | Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs | |
CY1113058T1 (el) | Συνδυαστικη θεραπεια για την αντιμετωπιση οφθαλμικων νεοαγγειακων διαταραχων | |
MXPA02000192A (es) | Composiciones y metodos para la terapia y diagnostico de cancer de pulmon. | |
WO2001096388A8 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
CY1110029T1 (el) | Γονιδιο που εκφραζεται στον καρκινο του προστατη | |
Koh et al. | Brain somatic mutations in epileptic disorders | |
Forero et al. | Analysis of functional polymorphisms in three synaptic plasticity-related genes (BDNF, COMT AND UCHL1) in Alzheimer's disease in Colombia | |
CY1105380T1 (el) | Προτιμωμενα τμηματα της νευρικης νηματικης πρωτεϊνης και μεθοδοι χρησης αυτων | |
NO20052956L (no) | Defensinprotiner | |
HUP0301812A2 (hu) | Átvizsgálási (screening) eljárás | |
CY1105566T1 (el) | Ποσοτικη διαγνωστικη αναλυση της προδιαθεσης για υπερταση | |
DK1536006T3 (da) | Cancerantigener og anvendelse deraf | |
CY1109029T1 (el) | Νουκλεϊνικο οξυ και αντιστοιχη πρωτεϊνη ονομαζομενη 85p1b3 χρησιμα στην αγωγη και τον εντοπισμο του καρκινου | |
WO2004070012A3 (en) | Cell-killing molecules and methods of use thereof | |
CY1114585T1 (el) | ΑΝΤΙΣΩΜΑΤΑ ΚΑΤΑ ΕΝΟΣ ΟΜΟΛΟΓΟΥ ΤΗΣ MDR p-ΓΛΥΚΟΠΡΩΤΕΪΝΗΣ ΕΠΑΝΩ ΣΤΟ ΧΡΩΜΟΣΩΜΑ 7p15-21 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΩΝ | |
Pathmarajah et al. | Generalized vitiligo in a psoriatic patient treated with ixekizumab. | |
ATE527370T1 (de) | Sparc-promotormutationen im zusammenhang mit arzneistoffresistenz sowie damit verbundene verfahren | |
DE60319342D1 (de) | N rheumatoider arthritis | |
WO2001096389A3 (en) | Compositions and methods for the therapy and diagnosis of colon cancer |